Image Trademark with Serial Number 79020265
Status: 706 - A Section 71 declaration has been accepted
Serial Number
79020265
Registration Number
3223297
Word Mark
Status
706 - A Section 71 declaration has been accepted
Status Date
2017-03-18
Filing Date
2005-06-28
Registration Number
3223297
Registration Date
2007-03-27
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s)
Typeset
Design Searches
070301, 261502, 280103 - Skyscrapers. Plain single or multiple line polygons. Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters.
Published for Opposition Date
2007-01-09
Law Office Assigned Location Code
L80
Employee Name
LAPTER, ALAIN J
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
the non-Latin characters that mean "North China"
Description of Mark
The marks consists of a hexagon within which is an outline of a building. Under the building are the Chinese characters with transliteration of "Hua Bei".
Goods and Services
Western medicine and patent medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; biochemical medicine, namely, recombinant human granulocyte-macrophage colony stimulating factor for injection for the prevention and treatment of leukocytopenia caused by chemotherapy or radiotherapy in cancer patients, recombinant human granulocyte colony stimulating factor injection for prevention and treatment of leukopenia caused by chemotherapy or radiotherapy, and neutrupenia following transplantation of bone marrow, recombinant human erythropoetin injection used for anemia cause by renal insufficiency, including patients with chronic renal failure treated with or without hemodialysis, recombinant hepatitis B surface antigen vaccines to get rid of the contamination of viruses contained in human blood; tonics in the nature of medicine, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; dietetic substances adapted for medical use, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; dietetic foods adapted for medical purposes; diagnostic preparations for medical purposes preparations for acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; fodder additives for medical purposes; nutritional additives for medical purposes; baby food; medical kits, comprising of antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; all kinds of pills all included in this class, in the nature of antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; insecticides; germicides; herbicides; agrochemical herbicides; gelatin for medical purposes; pectin containing preparations for pharmaceutical purposes, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; veterinary medicine, namely, blood serum for veterinary purpose, vaccines for veterinary purpose, diagnosticum for veterinary purpose, chemical material medicine for veterinary purpose, chemical preparations for veterinary purpose, antibiotics for veterinary purpose, biomedicine for veterinary purpose, radioactivity drug for veterinary purpose; medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; Chinese medicine material, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen; medical plasters; sanitary sterilizing preparations; isopropyl alcohol for medical use; glucose tablets used as a dietary supplement; starch for pharmaceutical purposes, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach; primary medicine of western medicine, namely, antibiotics, synthetic antibacterial, antiviral, tuberculosis drugs, cardio-cerebrovascular system drugs, cancer drugs, gastrointestinal tract drugs, vitamins, urinary system drugs, coenzyme and biochemical drugs, immunity drugs, antipsychotic drugs, acetaminophen, for the treatment of acute bronchitis, infective endocarditis, cutaneous abscesses, necrotizing subcutaneous infections, lymphadenitis, gonorrhea, mycoplasmal pneumonia, pneumonia, lung abscess, pulmonary tuberculosis, pyogenic ostcomyclitis, septicemia, pyelonephritis, nephritis, urinary infection, phlegmon, peritonsillar abscess, purulent arthritis, pyogenic ostcomyclitis, purulent meningitis, scarlet fever, syphilis, typhoid, influenza, infantile diarrhea, gastric ulcer, gastritis, cardiac arrhythmias, angina pectoris, arteriosclerosis, hyperlipemia, hypertension, cerebral thrombosis, peripheral neuropathies, megaloblastic anemia, iron deficiency anemia, immunosuppressive agent, diabetes mellitus, hepatitis, carcinoma of stomach
Translation of Words in Mark
The English translation of the foreign word(s) in the mark is: "HUA BEI" means "North China".
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2006-03-06
Primary Code
005
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
99 - Other (incorporated company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
99 - Other (incorporated company).
Address
Please log in with your Justia account to see this address.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Corporation).
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Corporation).
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Corporation).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
HEBEI TRADEMARK AGENCY CO., LTD
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
0875115
International Registration Date
2005-06-28
International Publication Date
2006-03-23
International Renewal Date
2025-06-28
Auto Protection Date
2007-09-02
International Status
001 - Request for extension of protection established
International Status Date
2006-03-02
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event Date | Event Description |
2006-03-02 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2006-03-06 | NEW APPLICATION ENTERED IN TRAM |
2006-03-06 | ASSIGNED TO EXAMINER |
2006-03-09 | NON-FINAL ACTION WRITTEN |
2006-03-10 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2006-03-15 | REFUSAL PROCESSED BY MPU |
2006-03-15 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2006-04-07 | REFUSAL PROCESSED BY IB |
2006-09-15 | PAPER RECEIVED |
2006-09-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2006-09-25 | AMENDMENT FROM APPLICANT ENTERED |
2006-11-07 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2006-11-09 | ASSIGNED TO LIE |
2006-11-20 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2006-12-20 | NOTICE OF PUBLICATION |
2007-01-09 | PUBLISHED FOR OPPOSITION |
2007-03-27 | REGISTERED-PRINCIPAL REGISTER |
2007-09-19 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2007-09-25 | FINAL DISPOSITION PROCESSED |
2007-09-25 | FINAL DISPOSITION NOTICE SENT TO IB |
2008-06-06 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2013-03-19 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2013-03-19 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2013-03-19 | TEAS SECTION 71 RECEIVED |
2013-04-03 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2013-04-03 | REGISTERED-SEC.71 ACCEPTED |
2013-04-03 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
2015-07-16 | INTERNATIONAL REGISTRATION RENEWED |
2016-03-27 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
2017-03-17 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2017-03-17 | TEAS SECTION 71 RECEIVED |
2017-03-18 | REGISTERED-SEC.71 ACCEPTED |
2017-03-18 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
2021-06-11 | CHANGE OF OWNER RECEIVED FROM IB |